会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Porphycene compounds for photodynamic therapy
    • 卟啉化合物用于光动力疗法
    • US5262401A
    • 1993-11-16
    • US875314
    • 1992-04-29
    • Emanuel VogelClemens RichertThomas BenninghausMartin MullerAlexander D. Cross
    • Emanuel VogelClemens RichertThomas BenninghausMartin MullerAlexander D. Cross
    • A61K41/00C07D487/22A61K31/70C07H15/00
    • C07D487/22A61K41/0057
    • A porphycene having the structure ##STR1## wherein each R.sup.1 is, independently, (a) --(CH.sub.2).sub.n --X, where n= 1-4, X is OR.sup.2 and R.sup.2 is C.sub.1-6 alkyl, aralkyl or aryl; CN; OH; OSO.sub.2 R.sup.2 ; NH.sub.2 ; NHR.sup.2 ; NR.sup.2.sub.2 ; SH; SR.sup.2 ; S(O).sub.1-2 R.sup.2 ; COOH; CO.sub.2 R.sup.2 ; C(O)NH.sub.2 ; C(O)NHR.sup.2 ; C(O)NR.sup.2.sub.2 ; halogen; or CHO;(b) --(CH.sub.2).sub.m CH.dbd.CH.sub.2 where m is 0-2; or(c) --(CH.sub.2).sub.n --O--G where G is a mono- or oligosaccharide;(d) --(CH.sub.2).sub.2n --X, where X is an amino acid, oligopeptide covalently bonded by an ether-, ester- or amine-bond or --Y--(CH.sub.2).sub.n -porphycene.sup.2 (porphycene.sup.2 being a compound of the same structure and Y is a direct bond; --O--; or --CH.dbd.CH.sub.2); or(e) where one, two or three of the substituents R.sup.1 are C.sub.1-6 alkyl or aryl and the remaining substituents are as above under (a)-(d), and salts and metal complexes thereof. The porphycene compounds and pharmaceutical compositions containing the compounds are useful in photodynamic therapy treatment of tumors and psoriasis.
    • 具有结构的卟菲烯,其中每个R 1独立地为(a) - (CH 2)n -X,其中n = 1-4,X为OR 2,R 2为C 1-6烷基,芳烷基或芳基; CN; 哦; OSO2R2; NH2; NHR2; NR22; SH; SR2; S(O)1-2R2; COOH; CO2R2; C(O)NH 2; C(O)NHR 2; C(O)NR22; 卤素; 或CHO; (b) - (CH 2)m CH = CH 2,其中m是0-2; 或(c) - (CH 2)n -O-G,其中G是单糖或寡糖; (d) - (CH2)2n-X,其中X是氨基酸,通过醚 - ,酯 - 或胺键共价结合的寡肽或-Y-(CH 2)n - 卟吩二(卟吩2是相同的化合物) 结构,Y是直接键; -O-;或-CH = CH 2); 或(e)其中一个,两个或三个取代基R 1为C 1-6烷基或芳基,其余取代基如上述(a) - (d)所述,及其盐和金属络合物。 含有这些化合物的卟吩化合物和药物组合物可用于肿瘤和牛皮癣的光动力疗法治疗。
    • 2. 发明授权
    • Porphycene compounds for photodynamic therapy
    • 卟啉化合物用于光动力疗法
    • US5409900A
    • 1995-04-25
    • US102772
    • 1993-08-06
    • Emanuel VogelClemens RichertThomas BenninghausMartin MullerAlexander D. Cross
    • Emanuel VogelClemens RichertThomas BenninghausMartin MullerAlexander D. Cross
    • A61K41/00C07D487/22A61K31/40
    • C07D487/22A61K41/0057
    • A porphycene having the structure ##STR1## wherein each R.sup.1 is, independently, (a) --(CH.sub.2).sub.n --X, where n=1-4, X is OR.sup.2 and R.sup.2 is C.sub.1-6 alkyl, aralkyl or aryl; CN; OH; OSO.sub.2 R.sup.2 ; NH.sub.2 ; NHR.sup.2 ; NR.sub.2.sup.2 ; SH; SR.sup.2 ; S(O).sub.1-2 R.sup.2 ; COOH; CO.sub.2 R.sup.2 ; C(O)NH.sub.2 ; C(O)NHR.sup.2 ; C(O)NR.sub.2.sup.2 ; halogen; or CHO;(b) --(CH.sub.2).sub.m CH.dbd.CH.sub.2 where m is 0-2; or(c) --(CH.sub.2).sub.n --O--G where G is a mono- or oligosaccharide;(d) --(CH.sub.2).sub.2n --X, where X is an amino acid, oligopeptide covalently bonded by an ether-, ester- or amine-bond or --Y-- (CH.sub.2).sub.n -porphycene.sup.2 (porphycene.sup.2 being a compound of the same structure and Y is a direct bond; --O--; or --CH.dbd.CH.sub.2); or(e) where one, two or three of the substituents R.sup.1 are C.sub.1-6 alkyl or aryl and the remaining substituents are as above under (a)-(d), and salts and metal complexes thereof. The porphycene compounds and pharmaceutical compositions containing the compounds are useful in photodynamic therapy treatment of tumors and psoriasis.
    • 具有结构的卟菲烯,其中每个R 1独立地为(a) - (CH 2)n -X,其中n = 1-4,X为OR 2,R 2为C 1-6烷基,芳烷基或芳基; CN; 哦; OSO2R2; NH2; NHR2; NR22; SH; SR2; S(O)1-2R2; COOH; CO2R2; C(O)NH 2; C(O)NHR 2; C(O)NR22; 卤素; 或CHO; (b) - (CH 2)m CH = CH 2,其中m是0-2; 或(c) - (CH 2)n -O-G,其中G是单糖或寡糖; (d) - (CH2)2n-X,其中X是氨基酸,通过醚 - ,酯 - 或胺键共价结合的寡肽或-Y-(CH 2)n - 卟吩二(卟吩2是相同的化合物) 结构,Y是直接键; -O-;或-CH = CH 2); 或(e)其中一个,两个或三个取代基R 1为C 1-6烷基或芳基,其余取代基如上述(a) - (d)所述,及其盐和金属络合物。 含有这些化合物的卟吩化合物和药物组合物可用于肿瘤和牛皮癣的光动力疗法治疗。
    • 3. 发明授权
    • Porphycene compounds for photodynamic therapy
    • 磷光化合物用于光动力疗法
    • US5179120A
    • 1993-01-12
    • US723394
    • 1991-06-28
    • Emanuel VogelClemens RichertThomas BenninghausMartin MullerAlexander D. Cross
    • Emanuel VogelClemens RichertThomas BenninghausMartin MullerAlexander D. Cross
    • A61K31/40A61K41/00A61K49/00A61P7/00A61P17/00A61P35/00C07D20060101C07D209/56C07D487/22
    • C07D487/22A61K41/0057
    • A porphycene having the structure ##STR1## wherein each R.sup.1 is, independently, (a) --(CH.sub.2).sub.n --X, where n=1-4, X is OR.sup.2 and R.sup.2 is C.sub.1-6 alkyl, aralkyl or aryl; CN; OH; OSO.sub.2 R.sup.2 ; NH.sub.2 ; NHR.sup.2 ; NR.sub.2.sup.2 ; SH; SR.sup.2 ; S(O).sub.1-2 R.sup.2 ; COOH; CO.sub.2 R.sup.2 ; C(O)NH.sub.2 ; C(O)NHR.sup.2 ; C(O)NR.sub.2.sup.2 ; halogen; or CHO;(b) --(CH.sub.2).sub.m CH.dbd.CH.sub.2 where m is 0-2; or(c) --(CH.sub.2).sub.n --O--G where G is a mono- or oligosaccharide;(d) --(CH.sub.2).sub.2n --X, where X is an amino acid, oligopeptide covalently bonded by an ether-, ester- or amine-bond or --Y--(CH.sub.2).sub.n -porphycene.sup.2 (porphycene.sup.2 being a compound of the same structure and Y is a direct bond; --O--; or --CH.dbd.CH.sub.2); or(e) where one, two or three of the substituents R.sup.1 are C.sub.1-6 alkyl or aryl and the remaining substituents are as above under (a)-(d), and salts and metal complexes thereof. The porphycene compounds and pharmaceutical compositions containing the compounds are useful in photodynamic therapy treatment of tumors and psoriasis.
    • 具有结构的卟菲烯,其中每个R 1独立地为(a) - (CH 2)n -X,其中n = 1-4,X为OR 2,R 2为C 1-6烷基,芳烷基或芳基; CN; 哦; OSO2R2; NH2; NHR2; NR22; SH; SR2; S(O)1-2R2; COOH; CO2R2; C(O)NH 2; C(O)NHR 2; C(O)NR22; 卤素; 或CHO; (b) - (CH 2)m CH = CH 2,其中m是0-2; 或(c) - (CH 2)n -O-G,其中G是单糖或寡糖; (d) - (CH2)2n-X,其中X是氨基酸,通过醚 - ,酯 - 或胺键共价结合的寡肽或-Y-(CH 2)n - 卟吩二(卟吩2是相同的化合物) 结构,Y是直接键; -O-;或-CH = CH 2); 或(e)其中一个,两个或三个取代基R 1为C 1-6烷基或芳基,其余取代基如上述(a) - (d)所述,及其盐和金属络合物。 含有这些化合物的卟吩化合物和药物组合物可用于肿瘤和牛皮癣的光动力疗法治疗。